Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

467 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Response to melphalan in up-front investigational window therapy for patients with metastatic Ewing's family tumours.
Luksch R, Grignani G, Fagioli F, Brach del Prever A, Podda M, Aliberti S, Casanova M, Prete A, Hanau G, Tamburini A, Allione P, Tienghi A, Ferrari S, Collini P, Marchianò A, Gandola L, Aglietta M, Madon E, Picci P, Fossati-Bellani F. Luksch R, et al. Among authors: aliberti s. Eur J Cancer. 2007 Mar;43(5):885-90. doi: 10.1016/j.ejca.2006.09.027. Epub 2007 Jan 24. Eur J Cancer. 2007. PMID: 17254770
Allogeneic hemopoietic stem cell transplantation in solid tumors.
Carnevale-Schianca F, Ricchiardi A, Capaldi A, Bucci AR, Grignani G, Rota-Scalabrini D, Fizzotti M, Aliberti S, Aglietta M. Carnevale-Schianca F, et al. Among authors: aliberti s. Transplant Proc. 2005 Jul-Aug;37(6):2664-6. doi: 10.1016/j.transproceed.2005.06.050. Transplant Proc. 2005. PMID: 16182778 Review.
Positron-emission tomography in cancer therapy.
Aliberti S, Grignani G, Aglietta M. Aliberti S, et al. N Engl J Med. 2006 May 4;354(18):1958-60; author reply 1958-60. N Engl J Med. 2006. PMID: 16673532 No abstract available.
Impact of a risk-based follow-up in patients affected by gastrointestinal stromal tumour.
D'Ambrosio L, Palesandro E, Boccone P, Tolomeo F, Miano S, Galizia D, Manca A, Chiara G, Bertotto I, Russo F, Campanella D, Venesio T, Sangiolo D, Pignochino Y, Siatis D, De Simone M, Ferrero A, Pisacane A, Dei Tos AP, Aliberti S, Aglietta M, Grignani G. D'Ambrosio L, et al. Among authors: aliberti s. Eur J Cancer. 2017 Jun;78:122-132. doi: 10.1016/j.ejca.2017.03.025. Epub 2017 Apr 24. Eur J Cancer. 2017. PMID: 28448856
Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group.
Grignani G, D'Ambrosio L, Pignochino Y, Palmerini E, Zucchetti M, Boccone P, Aliberti S, Stacchiotti S, Bertulli R, Piana R, Miano S, Tolomeo F, Chiabotto G, Sangiolo D, Pisacane A, Dei Tos AP, Novara L, Bartolini A, Marchesi E, D'Incalci M, Bardelli A, Picci P, Ferrari S, Aglietta M. Grignani G, et al. Among authors: aliberti s. Lancet Oncol. 2018 Oct;19(10):1360-1371. doi: 10.1016/S1470-2045(18)30438-8. Epub 2018 Sep 11. Lancet Oncol. 2018. PMID: 30217671 Free article. Clinical Trial.
467 results